LOSARTAN POTASSIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for losartan potassium and what is the scope of patent protection?
Losartan potassium
is the generic ingredient in two branded drugs marketed by Organon, Aiping Pharm Inc, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.There are thirty-eight drug master file entries for losartan potassium. Forty-seven suppliers are listed for this compound.
Summary for LOSARTAN POTASSIUM
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 24 |
NDAs: | 24 |
Drug Master File Entries: | 38 |
Finished Product Suppliers / Packagers: | 47 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Clinical Trials: | 86 |
Patent Applications: | 5,887 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for LOSARTAN POTASSIUM |
Drug Sales Revenues: | Drug sales revenues for LOSARTAN POTASSIUM |
What excipients (inactive ingredients) are in LOSARTAN POTASSIUM? | LOSARTAN POTASSIUM excipients list |
DailyMed Link: | LOSARTAN POTASSIUM at DailyMed |
Recent Clinical Trials for LOSARTAN POTASSIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gadjah Mada University | Phase 1/Phase 2 |
Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
Steadman Philippon Research Institute | Phase 2 |
Pharmacology for LOSARTAN POTASSIUM
Drug Class | Angiotensin 2 Receptor Blocker |
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for LOSARTAN POTASSIUM
Anatomical Therapeutic Chemical (ATC) Classes for LOSARTAN POTASSIUM
US Patents and Regulatory Information for LOSARTAN POTASSIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 090382-002 | Oct 6, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ipca Labs Ltd | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 200290-003 | Aug 30, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hetero Labs Ltd V | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 203835-001 | Aug 12, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 077459-003 | Oct 6, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOSARTAN POTASSIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-003 | Oct 13, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-001 | Apr 14, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-003 | Oct 13, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.